214 related articles for article (PubMed ID: 19357722)
1. Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy.
Lu TC; Wang ZH; Feng X; Chuang PY; Fang W; Shen Y; Levy DE; Xiong H; Chen N; He JC
Kidney Int; 2009 Jul; 76(1):63-71. PubMed ID: 19357722
[TBL] [Abstract][Full Text] [Related]
2. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes.
Okada S; Shikata K; Matsuda M; Ogawa D; Usui H; Kido Y; Nagase R; Wada J; Shikata Y; Makino H
Diabetes; 2003 Oct; 52(10):2586-93. PubMed ID: 14514644
[TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes.
Park IS; Kiyomoto H; Abboud SL; Abboud HE
Diabetes; 1997 Mar; 46(3):473-80. PubMed ID: 9032105
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
[TBL] [Abstract][Full Text] [Related]
5. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
[TBL] [Abstract][Full Text] [Related]
6. Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats.
Tone A; Shikata K; Sasaki M; Ohga S; Yozai K; Nishishita S; Usui H; Nagase R; Ogawa D; Okada S; Shikata Y; Wada J; Makino H
Diabetologia; 2005 Nov; 48(11):2402-11. PubMed ID: 16231067
[TBL] [Abstract][Full Text] [Related]
7. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats.
Usui H; Shikata K; Matsuda M; Okada S; Ogawa D; Yamashita T; Hida K; Satoh M; Wada J; Makino H
Nephrol Dial Transplant; 2003 Feb; 18(2):265-72. PubMed ID: 12543879
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
Kidney Int; 2014 Nov; 86(5):979-90. PubMed ID: 24827776
[TBL] [Abstract][Full Text] [Related]
9. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
10. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
Ninichuk V; Kulkarni O; Clauss S; Anders H-
Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
[TBL] [Abstract][Full Text] [Related]
11. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
[TBL] [Abstract][Full Text] [Related]
12. Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy.
Fujimoto M; Maezawa Y; Yokote K; Joh K; Kobayashi K; Kawamura H; Nishimura M; Roberts AB; Saito Y; Mori S
Biochem Biophys Res Commun; 2003 Jun; 305(4):1002-7. PubMed ID: 12767930
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
[TBL] [Abstract][Full Text] [Related]
14. Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation.
Usui HK; Shikata K; Sasaki M; Okada S; Matsuda M; Shikata Y; Ogawa D; Kido Y; Nagase R; Yozai K; Ohga S; Tone A; Wada J; Takeya M; Horiuchi S; Kodama T; Makino H
Diabetes; 2007 Feb; 56(2):363-72. PubMed ID: 17259380
[TBL] [Abstract][Full Text] [Related]
15. Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells.
Giunti S; Tesch GH; Pinach S; Burt DJ; Cooper ME; Cavallo-Perin P; Camussi G; Gruden G
Diabetologia; 2008 Jan; 51(1):198-207. PubMed ID: 17968528
[TBL] [Abstract][Full Text] [Related]
16. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats.
Sassy-Prigent C; Heudes D; Mandet C; Bélair MF; Michel O; Perdereau B; Bariéty J; Bruneval P
Diabetes; 2000 Mar; 49(3):466-75. PubMed ID: 10868970
[TBL] [Abstract][Full Text] [Related]
17. Critical role for osteopontin in diabetic nephropathy.
Nicholas SB; Liu J; Kim J; Ren Y; Collins AR; Nguyen L; Hsueh WA
Kidney Int; 2010 Apr; 77(7):588-600. PubMed ID: 20130530
[TBL] [Abstract][Full Text] [Related]
18. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential.
Chen HY; Huang XR; Wang W; Li JH; Heuchel RL; Chung AC; Lan HY
Diabetes; 2011 Feb; 60(2):590-601. PubMed ID: 20980457
[TBL] [Abstract][Full Text] [Related]
19.
Yoon JJ; Park JH; Kim HJ; Jin HG; Kim HY; Ahn YM; Kim YC; Lee HS; Lee YJ; Kang DG
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30841605
[TBL] [Abstract][Full Text] [Related]
20. Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels.
Pugliese G; Pricci F; Pesce C; Romeo G; Lenti E; Caltabiano V; Vetri M; Purrello F; Di Mario U
Diabetes; 1997 Jul; 46(7):1198-206. PubMed ID: 9200656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
